Availability Wegovy is already available, while Mounjaro is still being introduced in some UK clinics
has received honoraria from Boehringer Ingelheim, Eli Lilly, Merck, AstraZeneca, Sanofi, Mitsubishi-Tanabe, AbbVie, Janssen, Bayer, Prometic, Bristol Myers Squibb, Maze, Gilead, CSL-Behring, Otsuka, Novartis, Youngene and Novo Nordisk and has received operational funding for clinical trials from Boehringer Ingelheim, Eli Lilly, Merck, Janssen, Sanofi, AstraZeneca, CSL-Behring and Novo Nordisk
"And so like many areas of medicine, it depends on the patient." He continued, "One thing you have to remember is everybody doesn't need the most weight loss
Aggressive calorie restriction on a GLP-1 can cause muscle loss if protein intake isnt carefully managed
PMCID: PMC9838064 ) Neel NF, Ghobara Y, Turkmani M (2019) Liraglutide-induced injection site reaction
Yes, the clinical trial data suggest they produce very similar results